Virtual Reality Therapy for Arm Recovery (VVITA) Stroke
Condition(s) studied
Investigational drug(s) / intervention(s)
Experimental Group: A Personalized Adaptive Mirror Therapy for Upper-Limb Post-Stroke Rehabilitation using Virtual Reality and Myoelectric Control for 24 sesion in 8 weeks in add on to standard therapy.
Control Group: Conventional Therapy
Study summary
The study exploits new technologies appeared in the consumer electronics market to provide stroke patients with a low-cost, easy-to-use upper limb rehabilitation tool based on virtual reality. It aims to assess the potential, validity and participation in therapy while using virtual reality to improve limb rehabilitation through rehabilitation exercises that will use games chosen to improve the capabilities of the paretic upper limb. This therapy will be administered in addition to normal therapy and will be compared with a control group that will carry out the regular conventional therapy plus a neuromotor therapy dedicated to the upper limb of equal time and dose of interventional therapy.
Eligibility
Primary outcome measure(s)
- Motor procifiency assessed with FMA - UE — FMA - UE will be used for the initial evaluation of patients (Day 1), the intermediate one (Day 30) and at the end (Day 60).
The Fugl-Meyer Assessment Upper Extremity Scale (FMA-UE) is a widely recognized and utilized clinical tool designed to evaluate motor function, sensory function, balance, and joint range of motion in individuals who have experienced a stroke or other neurological impairments. The FMA-UE specifically focuses on the upper extremity, assessing the recovery of motor skills and coordination following neurological injuries.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS Fondazione Santa Lucia | Roma | Roma |
More I.R.C.C.S. Fondazione Santa Lucia trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07103122 on ClinicalTrials.gov ↗ ← All trials in Italy